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1. Introduction 
Detection of small molecules (hapten molecules), such as food contaminants, environmental 
pollutants, disease factors, drugs and so on, is an area with great significance. Immunoassay, 
as a simple, rapid and cost-effective detection system, is widely used for the detection of low 
molecular weight analytes in varied matrix. However, the number of commercial available 
immunoassay kits for hapten molecules is still limited, this might be partly due to the poor 
performance such as sensitivity of these immunoassays which can not fulfill the actual 
requirement. Traditionally, detection of small molecules in solution must employ competitive 
immunoassay formats, either with immobilized antibody or with immobilized coating 
conjugate. However, theoretical study has demonstrated that competitive immunoassays are 
inferior to noncompetitive immunoassays in terms of sensitivity, precision, kinetics and 
working range of analyte (Jackson and Ekins, 1986). Hence, there is a trend now to develop 
noncompetitive immunoassay systems for hapten molecules assay. 
Although sandwich immunoassay is widely applied to noncompetitive assay of antigen 
concentration, it has a fundamental limit that the antigen to be measured must be large 
enough to have at least two epitopes to be captured. Hence, it can not be used to measure 
low molecular weight compounds. During the last two decades, researchers in related fields 
have made great efforts to overcome this drawback, and some novel immunoassay systems 
that can noncompetitively detect small molecules have been established. These new formats 
are based on chemical modification to the analytes, unconventional antibodies (anti-idiotype 
antibody, anti-metatype antibody or antibody fragment), special separation steps (capillary 
electrophoresis, affinity column or membrane), or other elegant tricks. In this paper, an 
overview of the recent development and application of these elegant approaches was 
presented. 
2. Noncompetitive immunoassays based on chemical modification to the 
analytes 
2.1 Ishikawa’s method 
As stated, it is due to hapten molecules with just one epitope that can not simultaneously be 
bound by two antibodies, so traditional sandwich immunoassay can not be implemented. 
An ingenious scheme, developed by Ishikawa’s group in 1990, introduces a molecule of 
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biotin into the analyte prior to the assay, and then the biotinylated analyte can 
simultaneously be bound by anti-analyte antibody and avidin. According to this principle, a 
novel and sensitivity noncompetitive (two-site) enzyme immunoassay for haptens is 
described and exemplified by L-Thyroxine (T4) detection initially (Tanaka et al. 1990). The 
principle of this method is outlined in Figure 1. Briefly, samples (or standards) are firstly 
biotinylated, and then these biotinylated samples are purified by anti-analyte antibody 
coated polystyrene balls. Secondly, the samples are mixed with labeled anti-analyte 
antibody and transferred onto a solid phase coated with avidin. Finally, signal can be 
directly measured after a washing step. The signal strength is directly proportional to the 
analyte concentration as traditional noncompetitive immunoassay. 
 
Fig. 1. Principle of Ishikawa’s method. Step 1: biotinylation of the analyte and affinity 
purification; Step 2: formation of antibody/antigen complex; Step 3: captured by 
immobilized avidin. 
This method has been successfully applied to several analytes bearing a primary amino 
group, which can react with the biotin. The sensitivity of this technique is nearly 10 
attomoles for small peptides like angiotensin I (Ishikawa et al. 1990) or arginine vasopressin 
(Hashida et al. 1991). However, the biotinylated reaction and affinity purification 
procedures are complicated and time consuming. Due to this weakness, this method is not 
popularized to the detection of other hapten molecules. 
2.2 Solid phase immobilized epitope-immunoassay (SPIE-IA) 
The solid phase immobilized epitope-immunoassay (SPIE-IA) method for measuring hapten 
molecules in noncompetitive format was firstly described by Pradelles et al. in 1994 and its 
principle is outlined in Figure 2. The method involves a critical cross-linking and epitope 
release step. Briefly, the analyte is firstly captured by solid phase immobilized antibody, and 
then covalently cross-linked with corresponding antibody molecules by homobifunctional 
www.intechopen.com
 
Recent Progress in Noncompetitive Hapten Immunoassays: A Review  
 
55 
reagent (glutaraldehyde or disuccinimidyl suberate). After a dissociating treatment (HCl or 
methanol) of the analyte/antibody complex to release the epitope from the antibody 
binding site, the presence of analyte on the solid phase is detected using a labeled antibody. 
This procedure involves the use of excess reagents (capture and tracer antibodies) to insure 
the efficiency of analyte/antibody complexes formation and generates calibration curves in 
which the signal is directly proportional to the analyte concentration, as in conventional 
sandwich immunoassays (Pradelles et al. 1994). 
Like Ishikawa’s method, SPIE-IA was firstly applied to the measurement of analytes bearing 
a primary amino group excluded from the epitope site. But a prederivatization step before 
performing the SPIE-IA can be applied to introduce amino group to molecules that lack this 
function group. As in the work of Etienne et al.(1996), in order to develop a SPIE-IA system 
for thyroliberin, the thytoliberin and biological samples were prederivatized by diazotized 
2(4-amino-phenyl)ethyl amine, and then operated as the initial approach. With the aim of 
extending the procedure to haptens devoid of an amine moiety, new strategies of cross-
linking have been developed. For example, in another work of Etienne et al. (1995) the 
capacity of thyroxine to be photoactivated directly by UV treatment was utilized and 
resulting in covalent cross-linking with its binding protein. SPIE-IA involving direct cross-
linking of hapten by UV irradiation was then named as Photo-SPIE-IA, and it was also 
successfully applied to the detection of 17ß-estradiol (Buscarlet et al. 1999). More recently, 
new SPIE-IA procedure (named SPIE-Rad) using the free radical species produced by the 
Fenton-like reactions during the cross-linking step has been developed and also successfully 
applied to the detection of 17ǃ-estradiol (Buscarlet et al. 2001) 
 
Fig. 2. Principle of SPIE-IA. Step 1: immobilization of analyte on an anti-analyte antibody-
coated plate; Step 2: cross-linking of the analyte with solid-phase antibody and then 
dissociate the analyte/antibody complex; Step 3: analyte is revealed by labeled antibody. 
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As for the sensitivity, good results have been obtained by this method for various small 
analytes (<2500 Da) (Pradelles et al., 1994; Volland et al., 1994; Ezan et al., 1995; Volland et 
al., 1999). In each case, the sensitivity was enhanced (10–300 folds) when compared to the 
corresponding competitive immunoassay performed using the same antibody. For 
example, limit of detection of angiotensin II is close to 0.5 and 45pM with SPIE-IA and 
competitive assay, respectively (Volland et al., 1999). Moreover, the precision of SPIE-IA 
is equivalent to that of conventional immunoassays. Although, satisfactory performance 
was obtained from the published SPIE-IA, it is still very difficult to be applied to every 
hapten molecules.The UV irradiation approach appears limit due to the need for an 
irradiation device and the limited number of available irradiation wavelengths. In 
addition, UV irradiation has some deleterious effects by degrading the immunological 
complex more or less rapidly, depending on the wavelength and the energy used. The 
SPIE-Rad protocol might work efficiently to assay different molecules, but lots of 
parameters need to be optimized. 
3. Noncompetitive immunoassays based on unconventional antibody 
3.1 Anti-idiotype antibody based noncompetitive immunoassay (Idiometric assay) 
Anti-idiotype antibody (AId or Ab2), refering to an antibody raised against the variable 
region of an original antibody (Ab1), is one of the most important concepts on “immune 
network theory”. Jerne et al. (1982) have classified anti-idiotype antibodies according to the 
location of the idiotype recognization in their early report, and two main types of anti-
idiotype antibodies have been distinguished: alphatype (ǂ-AId) and betatype (ǃ-AId). By 
definition, ǂ-AId recognizes an epitope within the framework of the variable region of the 
primary antibody, but is not sensitive to the presence or absence of the analyte at the 
binding site. While, ǃ-AId compete with the antigen for an epitope at the binding site，i.e. 
the former will bind to the primary antibody in the presence of the antigen, whereas the 
latter will not. In addition, the ǂ-AId will not bind to the ǃ-AId/Ab1 complex because of 
steric hindrance. Based on the properties of ǂ-AId and ǃ-AId, Barnard and Kohen (1990) 
described an original noncompetitive immunoassay (denoted “idiometric assay”) for small 
molecules in 1990, and typified by the measurement of estradiol in serum. The general 
principle of this method is outlined in Figure 3. After coating wells with anti-hapten 
antibody (Ab1), test samples (or standard analytes) are added, and then ǃ-AId is used to 
block the binding sites that are not occupied by hapten molecules on the Ab1. At last, by 
adding labeled ǂ-AId, the amount of haptens can be detected. 
Since the establishment of this method, Barnard’s group has applied it to the detection of 
estradiol (Barnard & Kohen, 1990; Barnard et al., 1991; Mares et al., 1995) and progesterone 
(Barnard et al., 1995a) in serum and Estrone-3 Glucuronide (Barnard et al., 1995b) in urine， 
Kobayashi et al. have applied it to the detection of UDCA 7-NAG (a bile acid metabolite) 
(Kobayashi et al., 2000; Kobayashi et al., 2003 a) and 11-deoxycortisol (Kobayashi et al. 2003 
b). More recently, Niwa et al. (2009) established a noncompetitive-type ELISA for cortisol 
based on idiometric assay model. This assay had an approximately threefold higher 
sensitivity (detection limit: 90 pg cortisol) than a competitive ELISA using the same anti-
cortisol antibody and had practical specificity for providing reasonable determination of 
normal urinary cortisol levels. 
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Fig. 3. Principle of idiometric assay. Step 1: capture the analyte by anti-analyte antibody 
(Ab1)-coated plate; Step 2: blocking the unoccupied binding site on Ab1 by ǃ-AId; Step 3: 
analyte is revealed labeled ǂ-AId. 
Although good performances have been obtained, the idiometric assay requires the 
sequential addition of the three antibody reagents (capture antibody, ǂ-AId and ǃ-AId). The 
production of capture antibody is nothing special, but the production and identification of 
anti-idiotype antibody are very complicated. The difficulties inherent in anti-idiotype 
antibody generation, especially in producing an array of different AId, from which the most 
suited ones could be chosen, largely restrict the application of idiometric assay.  
3.2 Anti-metatype antibody based noncompetitive immunoassay 
The term "metatype" was initially proposed by Voss et al. (1988) for the immunological 
definition of the liganded active site to distinguish it from idiotype (non-liganded). Therefore, 
the anti-metatype antibodies recognize the antibody/antigen complex but exhibit very low or 
no affinity for the antibody or the antigen alone. This remarkable property was cleverly 
utilized by Self et al. (1994) to develop noncompetitive immunoassay for small molecules, and 
exemplified by digoxin detection. In this case, the analyte is captured by the specific antibody, 
and formatted a second epitope for anti-metatype antibody reorganization. If labeled anti-
metatype antibody is applied, a detect signal directly proportional to the analyte concentration 
can be obtained (Figure 4). 
Self et al. (1994) showed that this noncompetitive immunoassay system provides a high-
performance assay for digoxin in serum samples, being conveniently simple (immobilized 
primary antibody binds digoxin and then labeled secondary antibody so that when excess 
unbound label is washed away the immunometric readout reflects the digoxin 
concentration), rapid (incubation time 1-10 min), sensitive (detection limit 30 ng/L), precise 
(3-4% within-run CV, 1-8% total CV), and free from interference from digoxin-like 
immunoreactive factors. In addition, satisfactory results were also obtained by Towbin et al.  
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Fig. 4. Principle of anti-metatype antibody based noncompetitive immunoassay. Step 1: 
capture the analyte by anti-analyte antibody (Ab1)-coated plate; Step 2: labeled anti-
metatpye antibody was added for specifically bind to the analyte/antibody complex; Step 3: 
signal formation.  
(1995) and Nagata et al. (1999) for the detection of haptens angiotensin II and microcystin 
respectively. However, as per the idiometric assay, the difficulties of anti-metatype antibody 
production are main barriers for the widely application of this method. Such an anti-
metatype antibody can seldom be generated by the conventional antibody production 
methods, consequently, the information now available concerning the strategy for its 
production is very limited. 
3.3 Open sandwich immunoassay (OSIA) 
A new kind of noncompetitive immunoassay, named “open sandwich immunoassay 
(OSIA)”, has been described by Ueda et al. in 1996, and successfully applied to detect hen 
egg lysozyme (Ueda et al. 1996). This assay is based on the observation that for some 
antibodies, the association of separated VH and VL chains from the variable domain of 
antibody is strongly favored in the presence of antigen. The general principle of this method 
is outlined in Figure 5. Briefly, the VL fragment was immobilized on plate, and then the VL 
plate was incubated with VH fragment together with antigen. If labeled VH fragment is 
used, the signal can be directly measured after a washing step; otherwise a labeled second 
antibody is applied. After Ueda’s work, this method was extended to hapten molecules 
detection and new formats such as homogeneous assays were also developed. These 
homogeneous assay systems are either based on enzymatic complementation (Ueda et al. 
2003) or resonance energy transfer (fluorescence (Ueda et al. 1999; Arai et al. 2000; Wei et al. 
2006) or bioluminescence (Arai et al. 2001)).  
Up to now, the OSIA system has been successfully applied in the detection of hapten 
molecules such as gibberellin (Lee et al., 2008), benzaldehyde (Shirasu et al., 2009), zearalenone 
www.intechopen.com
 
Recent Progress in Noncompetitive Hapten Immunoassays: A Review  
 
59 
(Suzuki et al., 2007), 4-hydroxy-3-nitrophenylacetyl (Yokozeki et al. 2002), the carboxyl-
terminal peptide of human osteocalcin (BGP) (Lim et al. 2007), bisphenol A (Sakata et al. 
2009), and 11-Deoxycortisol (Ihara et al., 2009). This novel immunoassay system could be 
done in a shorter period of time than using a conventional sandwich assay, due to the 
omission of an incubation/washing cycle. And in the homogeneous format OSIA, the 
washing steps can even completely be avoided. Also, the assay was found to be compatible 
with traditional competitive immunoassay, similar or a lower detection limit as well as 
wider working range could be attained. However, the preparation of the reagents is complex 
and time consuming (production and selection of monoclonal antibodies; preparation of DNA 
fragments encoding VH and VL, construction, production and purification of fusion 
proteins). Moreover, the principle of this assay, based on differential interactions between 
separated VH and VL chains in the presence or absence of the antigen, requires a strong 
antibody selection since only some antibodies meet these criteria. For these reasons, it is still 
difficult to apply this method widely at present. 
 
Fig. 5. Principle of the initial OSIA. Step 1: immobilization of VL fragment; Step 2: 
incubation of labeled VH fragment with analyte; Step 3: measurement of signal. 
4. Noncompetitive immunoassay based on special separation steps 
4.1 Flow injection immunoassay (FIIA) 
Flow injection analysis (FIA) is developed in response to the need for automated analysis, in 
which a sample is injected into a continuous flow of a carrier solution mixed with other 
continuously flowing solutions before reaching a detector. FIA-based immunoassays were 
developed in the early 1980s. After that, Freytag et al. (1984) applied this flow injection 
immunoassay (FIIA) system to noncompetitive detection of hapten molecules and also 
exemplified by digoxin detection. This novel approach involves reaction of the sample with 
an excess of enzyme-labeled antibody. And this mixture is then passed through an affinity 
column containing immobilized antigen. The excess unreacted antibody is captured in the 
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column and only Ab-Ag complex is contained in eluate. At last, substrate is added and the 
concentration of the original antigen is related to the signal produced by the product of the 
enzymatic reaction (Figure 6). As it is developed, chemiluminescence and fluorescence 
labels are also applied to the FIIA system for further simplifying its operation. In addition, 
delicate modifications of this approach have been proposed by other groups. For example, 
Rabbany et al. used an activated porous membrane to immobilize antibody, then the labeled 
antigen was applied to saturating the binding sites. After which, target analyte is passed 
through the membrane, and the displacement of labeled antigen is monitored downstream. 
This method has been successfully applied to the detection of numerous hapten molecules 
and satisfactory sensitivity have been obtained: 10pM for thyroxine (Arefyev et al., 1990); 20 
pM for ǂ-(difluoromethyl) ornithine (Gunaratna et al., 1993) and 40pM for digoxigenin 
(Lovgren et al., 1997). The most inviting advantage of this method is the ability to realize 
automatic detection. For example, a semi-automated flow-through immunoassay system 
consisting of an amperometric immunosensor and reagent flow arrangements has been 
developed by Wilkins’s group (Abdel-Hamid et al., 1998). However, during the 
development of different assays, numerous parameters must be optimized. For instance, the 
column capacity, related to the immobilized analyte density and column dimensions, must 
allow removal of all excess free labeled antibody; and the residence time of the sample in the 
column, related to the flow rate and column dimensions, should be suitable for total binding 
of free labeled antibody but not so long as to risk the dissociation of the antibody and 
immobilized analyte (Volland et al., 2004). 
 
Fig. 6. Principle of FIIA. Step 1: Analyte is mixed with excess labeled antibody; Step 2: 
Separation of complex antibodies from free antibodies; Step 3: Signal measurement.  
4.2 Affinity probe capillary electrophoresis (APCE) 
A similar method, which relies on the high separating effect of capillary electrophoresis, was 
recently emerged for noncompetitive immunoassay of hapten molecules. This method is 
named as affinity probe capillary electrophoresis (APCE) and first described by Shimura 
and Karger (1994) using capillary isoelectric focusing for human growth hormone assay and 
further applied to small analytes by Hafner et al. (2000). In this case, the immune complex is 
separated from excess labeled antibody since the complexation of the antigen with the 
antibody induces small changes of electrophoretic behavior of the labeled antibody. 
The performances of this method are good, with a limit of detection of 5 pM for human 
growth hormone (Shimura and Karger, 1994) and 10pM for digoxin (Hafner et al. 2000), 
respectively. However, the correct separation appears difficult for some neutral analytes and 
the use of a charged analogue of the analyte is necessary to differentiate the complex from 
the unbound antibody. In addition, this technique only analyzes one sample at a time, thus 
limiting its potential application to routine assay of numerous samples (Volland et al., 2004). 
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5. Noncompetitive immunoassays based on other principles 
More recently, Tozzi’s group (2002) have invented a new noncompetitive immunoassay 
system with blocking of unoccupied specific binding sites on sold phase and exemplified 
this strategy by cortisol detection. This method is based on the use of a “blocking reagent”, 
which is able to bind to antibody sites not occupied by the analyte in a stronger way than 
the analyte itself. When a labeled analyte is added it substitutes the analyte in the antibody 
complex, but not the blocking reagent. Generally, this method includes the following steps: 
initially the analyte is bound to a specific binding partner, after which the unoccupied 
binding sites of the binding partner are inactivated by a blocker. Then, the bound analyte is 
dissociated from the binding partner and replaced by a labeled marker, after which the 
bound labeled marker is determined (Figure 7). The signal from the bound labeled marker is 
directly proportional to the initial amount of analyte in the sample. 
As to the performance of this method, results of Anfossi et al. (2002) showed that the 3σ 
limit of detection (LOD, 0.2 nmol/L) obtained by the above method was 10 times lower than 
that obtained by the corresponding ELISA, and recoveries in saliva samples ranged from 80 
to 120%. And recently, Acharya and Dhar (2008) have developed a novel broad-specific 
noncompetitive immunoassay for aflatoxins detection by the blocking & replacement 
method. In this work, an AFB1-protein conjugate was used as blocking reagent, and the 
limit of detection was 0.1 μg/L. Generally speaking, the key point of this method is to find 
an effective blocking reagent. 
 
Fig. 7. Principle of the blocking & replacement method. Step 1: the analyte is bound to a 
immobilized specific binding partner and then blocking reagent is applied to inactivate the 
unoccupied binding sites; Step 2: labeled analyte is applied to replace the bound analyte; 
Step 3: signal is developed and measured. 
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6. Conclusion 
From the literature and research finding above and others not concluded in this paper, a 
question might be put forward, which method is the best one that can be widely applied to 
most of the hapten molecules, it is not easy to answer this question, the answer may depend 
on what kind of analyte measured and the purpose of the analysis, but a comparative 
analysis of these methods could help researchers to choose the most suitable one for their 
purpose.  
The methods based on chemical modification to the analytes need an extra step to 
immobilize the target, apart from this step, it is very complicated and hard to standardize, 
whether it will work as we expect is a problem. X-ray analysis of hapten-antibody 
complexes have indicated that small molecules are buried deep in the binding site with 
surface areas of 200-400 Ǻ2 (Arevalo et al., 1993; Xu et al., 1999). Hence, although a model 
study have indicated that molecules constituting of two epitopes of only 300 Ǻ2 separated 
by a spacer as small as 5 Ǻ may be bound by two antibodies (Quinton et al., 2010), a 
optimization process of the spacer between biotin and analytes in Ishikawa’s method or 
between captured antibody and analytes in SPIE-IA is required. Otherwise, these methods 
may not work as per the principle.  
As to the methods based on unconventional antibody, the difficulties to prepare and 
identify these unusual antibodies are limitations for their wide application. However, once 
these specific antibodies have been prepared, these methods can easily be standardized. The 
recently developed phage display technology is a powerful and reliable technique for 
generating antibodies, and has successfully been applied to the preparation of anti-idiotype 
antibody (Goletz et al., 2002; Zhang et al., 2002; Raats et al., 2003;Coelho et al., 2004; Tometta 
et al., 2007) and anti-metatype antibody (Kim et al., 2009; Kim et al., 2010). Also, a phage 
display technology-based “split-Fv system” has recently been developed to rapidly evaluate 
and select antibody variable region (Fv) fragments that are suitable to open sandwich 
immunoassay (Aburatani et al., 2003). Along with the further improvement of the phage 
display technology, it will become the conventional method for the preparation of these 
unconventional antibodies, and then promote the wide application of idiometric assay, anti-
metatype antibody based immunoassay and open-sandwich immunoassay in the future. 
The methods based on special separation steps need extra equipment, but their greatest 
strength is the easiness to realize automatic detection. Along with the development of 
relevant separation technologies, this kind of method will become the choice for developing 
immunosensor to hapten molecules detection. 
As to the method based on “blocking reagent”, although various blocking reagents have 
been utilized in the published work, the available information concerning the strategy for 
their selection and the principle for their work is very limited. Hence, this type of 
noncompetitive immunoassay appears hard to wide application, unless a general 
preparation method and the inherent principle of the blocking reagent was available. 
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